Cited by 67Circadian rhythm and melatoninTreatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light

Tchekalarova, Jana, Stoynova, Tzveta, Ilieva, Kalina, Mitreva, Rumyana, Atanasova, Milena·2018·Pharmacology Biochemistry and Behavior

Abstract

Desynchronization of circadian rhythms is a hallmark of depression. The antidepressant agomelatine, which is an MT 1/MT 2 melatonin receptor agonist/5-HT 2C serotonin receptor antagonist has advantages compared to the selective serotonin reuptake inhibitors as a circadian phase-shifting agent. The present study was designed to explore whether agomelatine is able to have an antidepressant effect on rats exposed to chronic constant light (CCL) for 6 weeks. Focus is also placed on whether this activity affects diurnal rhythms of depressive-like symptoms and is associated with restoration of impaired circadian rhythms in plasma melatonin and corticosterone. We report that CCL induced a depressive-like symptoms associated with decreased grooming in the splash test during the subjective light/inactive phase. Anhedonia-like deficit in the saccharine preference test and increased immobility in the forced swimming test were both detected during the subjective dark/active phase. The disturbed emotional fluctuations due to CCL were corrected by agomelatine treatment (40 mg/kg, i.p. for 3 weeks). Agomelatine also restored novelty-induced hypophagia, which reflects an anxiety state, during the subjective Light and Dark phase, respectively, in rats exposed to CCL. Parallel to the observed positive influence on behavior, this melatonin analogue restored impaired circadian patterns of plasma melatonin but not that of corticosterone. These findings demonstrated the antidepressant-like effect of agomelatine in rats exposed to CCL possibly exerted via correction of melatonin rhythms and are suggestive of the therapeutic potential of this drug in a subpopulation of people characterized by a melatonin deficit.

Integrity signals

Registry

Crossref · 10.1016/j.pbb.2018.05.016

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administration of agomelatine to rats exposed to 3 and 6 weeks of constant light prevented the increase in depressive-like behavior and restored diurnal corticosterone and melatonin rhythms, respectively.

    “Administration of agomelatine to rats exposed to 3 and 6 weeks of constant light prevented the increase in depressive-like behavior and restored diurnal corticosterone and melatonin rhythms respectively93,94.”

    From Circadian rhythm disruption and mental health (2020) · cites this paper as [93]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tchekalarova, J., Stoynova, T., Ilieva, K., Mitreva, R., & Atanasova, M.
Affiliations
  • Bulgarian Academy of Sciences (BG)
  • Medical University Pleven (BG)
Corresponding author
Tchekalarova, Jana
Venue
Pharmacology Biochemistry and Behavior
Publisher
Elsevier BV
Published
2018-08
Volume
171
Pages
1-9
ISSN
0091-3057 (ISSN-L)
OpenAlex
W2804295521
Cited by
67
References
64
Citations by year
2026: 3 · 2025: 10 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 1
FWCI
4.23
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacology Biochemistry and Behavior (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Science Fund of Bulgaria (03/10, 11/4)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
agomelatine, depression, anxiety, melatonin, circadian rhythm, antidepressant effects, melatonin receptor agonists, circadian phase shifting, corticosterone, anhedonia, novelty-induced hypophagia
MeSH terms
Acetamides, Animals, Anxiety, Behavior, Animal, Circadian Rhythm, Corticosterone, Depression, Lighting, Male, Melatonin, Naphthalenes, Rats, Sleep Phase Chronotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review